{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T01:11:24Z","timestamp":1778721084777,"version":"3.51.4"},"publisher-location":"New York, NY","reference-count":22,"publisher":"Springer US","isbn-type":[{"value":"9781071650400","type":"print"},{"value":"9781071650417","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-1-0716-5041-7_20","type":"book-chapter","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:26:07Z","timestamp":1778718367000},"page":"421-435","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Systematic Production of IgG-Like Bispecific Antibodies via Intein-Mediated Protein Trans-Splicing"],"prefix":"10.1007","author":[{"given":"Hiroki","family":"Akiba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kouhei","family":"Tsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,14]]},"reference":[{"key":"20_CR1","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41573-019-0028-1","volume":"18","author":"AF Labrijn","year":"2019","unstructured":"Labrijn AF, Janmaat ML, Reichert JM et al (2019) Bispecific antibodies: a mechanistic review of the pipeline. Nat Rev Drug Discov 18:585\u2013608","journal-title":"Nat Rev Drug Discov"},{"key":"20_CR2","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1080\/19420862.2016.1268307","volume":"9","author":"U Brinkmann","year":"2017","unstructured":"Brinkmann U, Kontermann RE (2017) The making of bispecific antibodies. MAbs 9:182\u2013212","journal-title":"MAbs"},{"key":"20_CR3","doi-asserted-by":"publisher","first-page":"105955","DOI":"10.1016\/j.pep.2021.105955","volume":"188","author":"Y Li","year":"2021","unstructured":"Li Y (2021) IgG-like bispecific antibody platforms with built-in purification-facilitating elements. Protein Expr Purif 188:105955","journal-title":"Protein Expr Purif"},{"key":"20_CR4","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/nbt0798-677","volume":"16","author":"AM Merchant","year":"1998","unstructured":"Merchant AM, Zhu Z, Yuan JQ et al (1998) An efficient route to human bispecific IgG. Nat Biotechnol 16:677\u2013681","journal-title":"Nat Biotechnol"},{"key":"20_CR5","doi-asserted-by":"publisher","first-page":"e57479","DOI":"10.1371\/journal.pone.0057479","volume":"8","author":"Z Sampei","year":"2013","unstructured":"Sampei Z, Igawa T, Soeda T et al (2013) Identification and multidimensional optimization of an asymmetric bispecific IgG antibody mimicking the function of factor VIII cofactor activity. PLoS One 8:e57479","journal-title":"PLoS One"},{"key":"20_CR6","doi-asserted-by":"publisher","first-page":"11187","DOI":"10.1073\/pnas.1019002108","volume":"108","author":"W Schaefer","year":"2011","unstructured":"Schaefer W, Regula JT, Bahner M et al (2011) Immunoglobulin domain crossover as a generic approach for the production of bispecific IgG antibodies. Proc Natl Acad Sci U S A 108:11187\u201311192","journal-title":"Proc Natl Acad Sci U S A"},{"key":"20_CR7","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1080\/19420862.2015.1007816","volume":"7","author":"Y Mazor","year":"2015","unstructured":"Mazor Y, Oganesyan V, Yang C et al (2015) Improving target cell specificity using a novel monovalent bispecific IgG design. MAbs 7:377\u2013389","journal-title":"MAbs"},{"key":"20_CR8","doi-asserted-by":"publisher","first-page":"5145","DOI":"10.1073\/pnas.1220145110","volume":"110","author":"AF Labrijn","year":"2013","unstructured":"Labrijn AF, Meesters JI, de Goeij BECG et al (2013) Efficient generation of stable bispecific IgG1 by controlled Fab-arm exchange. Proc Natl Acad Sci U S A 110:5145","journal-title":"Proc Natl Acad Sci U S A"},{"key":"20_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18477-7","volume":"11","author":"S Dengl","year":"2020","unstructured":"Dengl S, Mayer K, Bormann F et al (2020) Format chain exchange (FORCE) for high-throughput generation of bispecific antibodies in combinatorial binder-format matrices. Nat Commun 11:4974","journal-title":"Nat Commun"},{"key":"20_CR10","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1080\/15216540500163343","volume":"57","author":"FB Perler","year":"2005","unstructured":"Perler FB (2005) Protein splicing mechanisms and applications. IUBMB Life 57:469\u2013476","journal-title":"IUBMB Life"},{"key":"20_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-08641-3","volume":"7","author":"L Han","year":"2017","unstructured":"Han L, Chen J, Ding K, Zong H et al (2017) Efficient generation of bispecific IgG antibodies by split intein mediated protein trans-splicing system. Sci Rep 7: 8360","journal-title":"Sci Rep"},{"key":"20_CR12","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ymeth.2018.10.001","volume":"154","author":"L Han","year":"2019","unstructured":"Han L, Zong H, Zhou Y et al (2019) Naturally split intein Npu DnaE mediated rapid generation of bispecific IgG antibodies. Methods 154:32\u201337","journal-title":"Methods"},{"key":"20_CR13","doi-asserted-by":"crossref","unstructured":"Sun R, Zhou Y, Han L et al (2021) A rational designed novel bispecific antibody for the treatment of GBM. Biomedicines 9:640","DOI":"10.3390\/biomedicines9060640"},{"key":"20_CR14","doi-asserted-by":"publisher","first-page":"803059","DOI":"10.3389\/fphar.2022.803059","volume":"13","author":"L Wang","year":"2022","unstructured":"Wang L, Qiao Y, Zong H et al (2022) IgG-like bispecific antibody CD3xEpCAM generated by split intein against colorectal cancer. Front Pharmacol 13:803059","journal-title":"Front Pharmacol"},{"key":"20_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-98855-3","volume":"11","author":"H Akiba","year":"2021","unstructured":"Akiba H, Ise T, Nagata S et al (2021) Production of IgG1-based bispecific antibody without extra cysteine residue via intein-mediated protein trans-splicing. Sci Rep 11:19411","journal-title":"Sci Rep"},{"key":"20_CR16","doi-asserted-by":"publisher","first-page":"1731938","DOI":"10.1080\/19420862.2020.1731938","volume":"12","author":"T Hofmann","year":"2020","unstructured":"Hofmann T, Schmidt J, Ciesielski E et al (2020) Intein mediated high throughput screening for bispecific antibodies. MAbs 12:1731938","journal-title":"MAbs"},{"key":"20_CR17","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/s42003-023-05326-8","volume":"6","author":"H Akiba","year":"2023","unstructured":"Akiba H, Fujita J, Ise T et al (2023) Development of a 1:1-binding biparatopic anti-TNFR2 antagonist by reducing signaling activity through epitope selection. Commun Biol 6:987","journal-title":"Commun Biol"},{"key":"20_CR18","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1021\/jacs.5b13528","volume":"138","author":"AJ Stevens","year":"2016","unstructured":"Stevens AJ, Brown ZZ, Shah NH et al (2016) Design of a split intein with exceptional protein splicing activity. J Am Chem Soc 138:2162\u20132165","journal-title":"J Am Chem Soc"},{"key":"20_CR19","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1016\/j.febslet.2006.02.045","volume":"580","author":"H Iwai","year":"2006","unstructured":"Iwai H, Z\u00fcger S, Jin J et al (2006) Highly efficient protein trans-splicing by a naturally split DnaE intein from Nostoc punctiforme. FEBS Lett 580:1853\u20131858","journal-title":"FEBS Lett"},{"key":"20_CR20","doi-asserted-by":"crossref","unstructured":"Motohashi K (2017) Seamless Ligation Cloning Extract (SLiCE) method using cell lysates from laboratory Escherichia coli strains and its application to SLiP site-directed mutagenesis. In: Reeves A (ed) In vitro mutagenesis: methods and protocols. Springer New York, New York, pp 349\u2013357","DOI":"10.1007\/978-1-4939-6472-7_23"},{"key":"20_CR21","doi-asserted-by":"publisher","unstructured":"Keilkopf CL, Bauer W, Urbatsch IL (2021) Sodium dodecyl sulfate\u2013polyacrylamide gel electrophoresis of proteins. Cold Spring Harb Protoc 2021. https:\/\/doi.org\/10.1101\/pdb.prot102228","DOI":"10.1101\/pdb.prot102228"},{"key":"20_CR22","doi-asserted-by":"crossref","unstructured":"Gasteiger E (2005) Protein identification and analysis tools on the expasy server. In: Walker JM (ed) The proteomics protocols handbook. Humana Press Inc., Totowa, NJ, pp 571\u2013607","DOI":"10.1385\/1-59259-890-0:571"}],"container-title":["Methods in Molecular Biology","Antibody Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-5041-7_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:26:08Z","timestamp":1778718368000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-5041-7_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9781071650400","9781071650417"],"references-count":22,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-5041-7_20","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"14 May 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"This study was funded by Japan Agency for Medical Research and Development (grant number JP22ak0101099) and Takeda Science Foundation. The authors have no other conflicts of interest to declare that are relevant to the content of this chapter.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}